Iterum Therapeutics plc
Pharmaceutical Preparations · DUBLIN 1
High confidence (80%)
Updated Oct 16, 2026, 12:04 AM
What is happening
Derived by rule set status-rules-2026.09.7
The company told the SEC it entered bankruptcy or receivership. Which of the two, the filing does not say.
Latest material event: Iterum Therapeutics plc was delisted from its exchange (Jun 23, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Iterum Therapeutics plc was delisted from its exchange
Jun 23, 2026
Delisting effective
- SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001659323 Iterum Therapeutics plc 333-224582 Block 2 Floor 3, Harcourt Centre Harcourt Street Dublin L2 IRELAND D02 312-778-6070 Ordinary Shares 17 CFR 240.12d2-2(b) Aravind Menon Hearings Advisor 2026-06-23”
Iterum Therapeutics plc received a delisting notice from its exchange
Mar 30, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously reported, on February 24, 2026, Iterum Therapeutics plc (the Company ) received a delisting determination letter (the Prior Determination Letter ) from The Nasdaq Stock Market LLC ( Nasdaq ) indicating that as a result of the Company s failure to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, the Company s ordinary shares were scheduled for delisting and would be suspended from trading on Nasdaq (the Prior Delisting D…”
Iterum Therapeutics plc reported entering bankruptcy or receivership
Mar 27, 2026
Bankruptcy or receivership reported
- SEC EDGAR — “Item 1.03 Bankruptcy or Receivership. On March 27, 2026, Iterum Therapeutics plc (the Company ) filed a petition in the High Court in Ireland to wind up the Company (the Winding Up Petition ). An order was made appointing Damien Murran and Jennifer McMahon, each of Teneo Restructuring (Ireland) Limited (the Joint Provisional Liquidators ), as Joint Provisional Liquidators to the Company. The petition is due to be heard on April 13, 2026. If a winding up order is made by the High Court, the Joint Provisional Liquidators will be confirmed as Joint Liquidators of the Company, and will result in t…”
Iterum Therapeutics plc received a delisting notice from its exchange
Feb 24, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 24, 2026, Iterum Therapeutics plc (the Company ) received a delisting determination letter (the Determination Letter ) from The Nasdaq Stock Market LLC ( Nasdaq ). The Determination Letter indicated that, as a result of the Company s previously disclosed and continued noncompliance with Nasdaq Listing Rule 5550(a)(2), which requires the Company to maintain a minimum bid price of $1.00 per share (the Bid Price Rule ) for continued listing on The Nasdaq Capital Market, the C…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker ITRMF on OTC.
- SEC CIK
- 0001659323
- Website
- —
- —
- Headquarters
- DUBLIN 1
- Also known as
- Iterum Therapeutics Ltd
- Legal entities
- Iterum Therapeutics plc
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Iterum Therapeutics plc — Pharmaceutical Preparations (SIC 2834) — DUBLIN 1, Ireland
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously reported, on February 24, 2026, Iterum Therapeutics plc (the Company ) received a delisting determination letter (the Prior Determination Letter ) from The Nasdaq Stock Market LLC ( Nasdaq ) indicating that as a result of the Company s failure to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, the Company s ordinary shares were scheduled for delisting and would be suspended from trading on Nasdaq (the Prior Delisting D…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 1.03 Bankruptcy or Receivership. On March 27, 2026, Iterum Therapeutics plc (the Company ) filed a petition in the High Court in Ireland to wind up the Company (the Winding Up Petition ). An order was made appointing Damien Murran and Jennifer McMahon, each of Teneo Restructuring (Ireland) Limited (the Joint Provisional Liquidators ), as Joint Provisional Liquidators to the Company. The petition is due to be heard on April 13, 2026. If a winding up order is made by the High Court, the Joint Provisional Liquidators will be confirmed as Joint Liquidators of the Company, and will result in t…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 24, 2026, Iterum Therapeutics plc (the Company ) received a delisting determination letter (the Determination Letter ) from The Nasdaq Stock Market LLC ( Nasdaq ). The Determination Letter indicated that, as a result of the Company s previously disclosed and continued noncompliance with Nasdaq Listing Rule 5550(a)(2), which requires the Company to maintain a minimum bid price of $1.00 per share (the Bid Price Rule ) for continued listing on The Nasdaq Capital Market, the C…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0001354457 Nasdaq Stock Market LLC 0001659323 Iterum Therapeutics plc 333-224582 Block 2 Floor 3, Harcourt Centre Harcourt Street Dublin L2 IRELAND D02 312-778-6070 Ordinary Shares 17 CFR 240.12d2-2(b) Aravind Menon Hearings Advisor 2026-06-23
View source record
Status history
Every derived status, with the rule that produced it.
- BANKRUPTCY → BANKRUPTCYSEC_BANKRUPTCY_OR_RECEIVERSHIP · Sep 18, 2026, 01:31 AM
The company told the SEC it entered bankruptcy or receivership. Which of the two, the filing does not say.
- BANKRUPTCY → BANKRUPTCYSEC_BANKRUPTCY_OR_RECEIVERSHIP · Sep 18, 2026, 01:13 AM
The company told the SEC it entered bankruptcy or receivership. Which of the two, the filing does not say.
- BANKRUPTCY → BANKRUPTCYSEC_BANKRUPTCY_OR_RECEIVERSHIP · Sep 15, 2026, 12:33 PM
The company told the SEC it entered bankruptcy or receivership. Which of the two, the filing does not say.
- BANKRUPTCY → BANKRUPTCYSEC_BANKRUPTCY_OR_RECEIVERSHIP · Sep 14, 2026, 04:44 PM
The company told the SEC it entered bankruptcy or receivership. Which of the two, the filing does not say.
- DISTRESS_SIGNAL → BANKRUPTCYSEC_BANKRUPTCY_OR_RECEIVERSHIP · Sep 8, 2026, 04:24 AM
The company told the SEC it entered bankruptcy or receivership. Which of the two, the filing does not say.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:16 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.